<img alt="" height="1" width="1" />Prometheus Revenue, Profit Rise As It Puts Focus On Drug SalesWall Street JournalPrometheus began marketing Lotronex, which it bought from GlaxoSmithKline PLC (GSK), for irritable bowel syndrome in late 2007 and Proleukin, ...<nobr></nobr> |